20:30 IST
NSE
Board Meeting Outcome
Vaishali Pharma Board Meeting Outcome
Vaishali Pharma's Board approved increasing authorized share capital from ₹27 Cr to ₹29 Cr. The proposal requires member approval and MoA amendments.
Vaishali Pharma Ltd
- Share price
- ₹8.10
- Market cap
- ₹109.3 Cr
- Revenue (annual)
- ₹108.8 Cr
- Net profit (annual)
- ₹4.16 Cr
- P/E (TTM)
- 24.7×Sector 47.3×
- Promoter holding
- 30.54%-1.07% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Financial Results 4Annual General Meeting 4Capital Structure Change 3Board Meeting Date 3Board Meeting Outcome 2Price Movement Clarification 1Management Change 1
Time
2 announcements with these filters
15:46 IST
NSE
Board Meeting Outcome
Vaishali Pharma Board Meeting Outcome
Vaishali Pharma approved the five-year re-appointment of its Independent, Managing, and Whole-Time Directors. These leadership extensions ensure management continuity and strategic stability for shareholders.
- Execution
- 5 years